Affirm Expands CPP Funding to $1.7B, But Valuation Remains Stretched

What happened

Affirm announced an expanded loan purchase commitment from CPP Investments totaling $1.7 billion, expected to support approximately $8 billion in consumer loan volume over two years. This reinforces Affirm's funding capacity, which has been a key risk given its leveraged balance sheet and reliance on securitizations. The deal follows other recent institutional funding expansions, signaling continued investor appetite for BNPL assets. However, the master report rates Affirm a potential sell: at over 100x earnings and 200% above a DCF intrinsic value, the stock prices in optimistic assumptions that leave little margin for error. With net debt/EBITDA around 9x and sector delinquencies elevated, the additional funding does not address the core valuation or credit risks.

Implication

The expanded CPP facility lowers near-term funding risk and supports growth, but the stock’s extreme valuation and thin equity cushion make it vulnerable to credit or regulatory shocks. Investors should wait for a better entry point or evidence of sustained prudent credit performance.

Thesis delta

The CPP expansion is a tactical positive for funding, but our structural thesis remains bearish. The stock's price still reflects a premium that far exceeds any reasonable intrinsic value, and the leveraged business model remains exposed to credit and funding cycles. Therefore, we maintain our sell stance; no upgrade warranted.